The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $114.46
Prev Close: $116.09
Open: $115.56
Bid: $114.46
Ask: $114.98
Day's Range: $113.82 - $115.87
52wk Range: $74.52 - $129.06
Volume: 2,732,808
Avg Vol 5,027,262
Market Cap: $91B
P/E (ttm): 39.76
EPS (ttm): $2.92
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Celgene from

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
1972 Outperform
74 Underperform
CAPS All Stars
493 Outperform
12 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

95% Approve

Based on 56 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.